(Q34447391)

2 August 2017

Disposition of metronidazole and its effects on sulphasalazine metabolism in patients with inflammatory bowel disease (English)

1 reference

inflammatory bowel diseases

2 August 2017

0 references

1 reference

Shaffer JL

1

1 reference

2 August 2017

Kershaw A

series ordinal

2

1 reference

2 August 2017

Houston JB

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 1986

1 reference

British Journal of Clinical Pharmacology

2 August 2017

1 reference

2 August 2017

21

1 reference

2 August 2017

4

1 reference

2 August 2017

431-435

1 reference

High-dose metronidazole: pharmacokinetics and bioavailability using an iv preparation and application of its use as a radiosensitizer.

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400944

Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400944

Absorption of prednisolone in patients with Crohn's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400944

Azo reduction of sulphasalazine in healthy volunteers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400944

A comparative study of metronidazole and sulfasalazine for active Crohn's disease: the cooperative Crohn's disease study in Sweden. II. Result

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400944

The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400944

The effect of rifampicin on sulphapyridine plasma concentrations following sulphasalazine administration

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400944

Determination of metronidazole and its two major metabolites in biological fluids by high pressure liquid chromatography

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400944

Bioavailability of metronidazole in fasting and non-fasting healthy subjects and in patients with Crohn's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1400944

The pharmacokinetics of oral and intravenous metronidazole in man

6 July 2018

1 reference

12 December 2020

HA-966 effects on striatal dopamine metabolism: implications for dopamine compartmentalization

1 reference

12 December 2020

Clinical Effect of Metronidazole and Sulfasalazine on Crohn's Disease in Relation to Changes in the Fecal Flora

1 reference

12 December 2020

Pharmacokinetics of metronidazole in patients with enteric disease compared to normal volunteers

1 reference

12 December 2020

10.1111/J.1365-2125.1986.TB05218.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference